Association of Sst I polymorphism in apolipoprotein C3 gene with Hypertriglyceridaemia in coronary atherosclerotic heart disease and type II diabetes mellitus in Chinese population

Acta Genetica Sinica

Volumn 32, Issue 1, 2005, Pages 11-18

  Liu, He Kun ^a,b   Li, Xue Fei ^b   Zhang, Si Zhong ^a   Ren, Yan ^a   Ma, Yong Xin ^a   Liu, Yun Qiang ^a   Wang, Chun Ting ^b   Chen, Xiang ^a   Hu, Yao Min ^a   Zhang, Li ^a  

^a SICHUAN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apolipoprotein C3 gene (APOC3); Coronary atherosclerotic heart disease (CHD); Hypertriglyceridaemia (HTG); Single nucleotide polymorphism (SNP); Type II diabetes mellitus (NIDDM)

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN C3; TRIACYLGLYCEROL;

ADULT; AGED; APOLIPOPROTEIN A1 GENE; APOLIPOPROTEIN A4 GENE; APOLIPOPROTEIN A5 GENE; APOLIPOPROTEIN C3 GENE; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; GENE; GENE CLUSTER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; POLYMORPHIC LOCUS; POPULATION GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SST I LOCUS;

AGED; APOLIPOPROTEIN C-III; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TRIGLYCERIDES;

EID: 19944431371     PISSN: 03794172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Van Dijk K W, Pensen P C, Voshol P J, Havekes L M. The role and mode of action of apolipoproteins C III and AV: synergistic actors in triglyceride metabolism? Curr Opin Lipidol,2004,15(3): 239-246.
2. Geurian K, Pinson J B, Weart C W. The triglyceride connection the atheroslerosis. Ann Pharmacother,1992,26:1109-1117.
3. Marcais C, Bernard S, Merlin M, Ulhmann M, Mestre B, Rochet-Mingret L, Revol A, Berthezene F, Moulin P. Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst I polymorphism, LPL mutations and apo E3 deficiency. Diabetologia,2000,43:1346-1352.
4. Wang C S, McConathy W J, Kloer H U, Alaupovic P. Modulation of lipoprotein lipase activity by apolipoprotein C3. J Clin Invest,1985,75:384-390.
5. Ito Y, Azrolan N, O'Connell A, Walsh A. Hypertriglyceridemia as a result of human apoC III gene expression in transgenic mice. Science,1990,249:790-793.
6. Water-worth D M, Ribalta J, Nicaud V, Dallongeville J, Humphries S E, Talmud P. ApoC III gene variants modulate postprandial response to both glucose and fat tolerance tests. Circulation,1999,99(14): 1872-1877.
7. Chhabra S, Narang R, Lakshmy R, Vasisht S, Agarwal D P, Srivastava L M, Manchanda S C, Das N. Apolipoprotein C3 Sst I polymorphism in the risk assessment of CAD. Mol Cell Biochem,2004,259(1-2): 59-66.
8. Chhabra S, Narang R, Krishnan L R, Vasisht S, Agarwal D P, Srivastava L M, Marchanda S C, Das N. Apolipoprotein C3 Sst I polymorphism and triglyceride levels in Asian Indians. BMC Genetics,2002,3:9.
9. Olivieri O, Stranieri C, Bassi A, Bassi A, Zaia B, Girelli D, Pizzolo F, Trabetti E, Cheng S, Grow M A, Pignatti P F, Corrocher R. Apo C III gene polymorphism and risk of coronary artery disease. J Lipid Res,2002,43:1450-1457.
10. Olivier M, Wang X, Cole R, Gau B, Kim J, Rubin EM, Pennacchio LA. Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Genomics,2004,83:912-923.
11. LIU He-Kun, WANG Chun-Ting, ZHANG Si-Zhong, XIAO Cui-Ying, LI Xue-Fei, ZHANG Ke-Lan, ZHANG LI, SU Zhi-Guang, MA Yong-Xin, ZHOU Bin, ZHENG Ke-Qin, LI Gui-Xing. Association of APOA5 gene SNP4 with levels of lipids and CHD in Chinese. Chin J Med Genet,2004,21(4): 335-338.
12. Maeda N, Li H, Lee D, Oliver P, Quarfords S H, Osada J. Targeted disruption of the apolipoprotein C-III gene in mice results in hypertriglyceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem. 1994,269(38): 23610-23616.
13. LIU Rui, BAI Huai, LIU Yu, HUANG Ming-Hui, LIU Bing-Wen. Apolipoprotein C III gene Sst I polymorphism in patients with endogenous hypertriglyceridemia in Chinese population. J WCUMS,2001,32(2): 175-178.
14. Russo G T, Meigs J B, Cupples L A, Demissie S, Otvos J D, Wilson P W, Lahoz C, Cucinotta D, Couture P, Mallory T, Schaefer E J, Ordovas J M. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis,2001,158(1): 173-181.
15. Shoulders C C, Grantham T T, North J D, Gaspardone A, Tomai F, de Fazio A, Versaci F, Gioffre P A, Cox N J. Hypertriglyceridemia and the apolipoprotein C III gene locus: lack of association with the variant insulin response element in Italian school children. Hum Genet,1996,98:557-566.
16. Tas Slnan. Strong association of a single nucleotide substitution in the 3′-untranslated region of the apolipoprotein-C III gene with common with hypertriglyceridenia in Arabs. Clin. Chem,1989,35(2): 256-259.
17. Hong S H, Park W H, Lee C C, Song J H, Kim J Q. Association between genetic variations of apo A I -C III -AIV cluster gene and hypertriglyceridemic subjects. Clin Chem, 1997,43:13-17.
18. REN Van, TIAN Hao-Ming, LIU Rui, LIU Bing-Wen, LIANG Jin-Zhong. Apolipoprotein C III gene polymorphism in patients of type 2 diabetes mellitus with hypertriglyceredia. Chin J Endocrinol Metab,2000,16(4): 220-223.
19. MENG Xiang-Wen, ZHANG Gui-Yin, LI Pu, DU Yang-Zhu. DNA polymorphisms and haplotypes in the apoA1 -C III gene region and coronary heart disease. Acta Genetica Sinica,1990,17(6): 411-417.
20. DAN Qing-Hong, HUANG Yuan-Wei, PENG Zhang-Ping, LIU Zhong, HAN Yang, JIN Zheng-Ming, JUN Jian. DNA polymorphisms of the apoA I -CIII -AIV gene cluster in coronary artery disease. National Medical Journal of China, 1995,75(10): 584-587.
21. Dammerman M, Sandkuijl L A, Halaas J L, Chung W, Breslow J L. An apolipoprotein C III haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphism. Proc Natl Acad Sci. USA,1993,90:4562-4566.
22. Li W W, Dammerman M M, Smith J D, Metzger S, Breslow J L, Leff T. Common genetic variation in the promoter of the human apoC III gene abolishes regulation by insulin and may contribute to hypertriglyceidemia. J Clin Invest,1995, 96:2601-2605.
23. Tamlud P J, Hawe E, Martin S, Olivier M, Miller G J, Rubin E M, Pennacchio L A, Humphries S E. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Human Molecular Genetics, 2002,11(24): 3039-3040.